Here’s everything ASX investors need to know on Friday morning…
Here’s what financial planners need to know Friday morning. The ASX 200 followed Wall Street’s lead down on Thursday, falling 1.7% and finishing at just 5.319 points.
Here’s what Australian financial planners and advisers need to know on Thursday morning…
US Federal Reserve Chairman Jerome Powell’s comment that the additional stimulus would be required and an intimation that global shutdowns may need to be reinstated sent the S&P 500 down another 1.5% and the Dow Jones 2.1%.
The ASX 200 is likely to start trading lower on Wednesday, according to futures contracts in Sydney.
Australia’s S&P/ASX 200 (ASX: XJO) is expected to start trading down at first today, according to futures trading in Sydney. Here’s everything investors like you need to know about the local market on Wednesday.
Australia’s ASX 200 is expected to open slightly lower on Tuesday according to the Sydney Futures Exchange.
The ASX 200 is likely to open slightly lower on Tuesday according to the Sydney Futures Exchange, following mixed results from global markets overnight.
Cochlear is one of the world’s leading medical device businesses. Cochlear designs, manufactures and supplies the Nucleus cochlear implant, the Hybrid electro-acoustic implant and the Baha bone conduction implant. Graeme Clark invented the first device in 1982, allowing first-user Graham Carrick to hear for the first time for 17 years. Some of the most recent…
In recent years, it seems that there can’t be an investment opportunity without an acronym – but sometimes, it’s more than a bit of alphabetical fun. The hybrid securities world first got into the acronym craze, such that investors saw listed on the ASX such interesting offers as Sydney Airport’s SKIES (Sydney Kingsford Smith Interest…
